Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
SB0170 • 2026
Vitamin K Amendments
This bill passed the Legislature and reached final enactment based on the latest official action.
Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.
This bill addresses vitamin K for newborn infants.
Governor Signed
Senate/ received enrolled bill from Printing
Senate/ to Governor
Enrolled Bill Returned to House or Senate
Senate/ enrolled bill to Printing
Bill Received from Senate for Enrolling
Draft of Enrolled Bill Prepared
Senate/ received from House
Senate/ signed by President/ sent for enrolling
House/ received from Senate
House/ signed by Speaker/ returned to Senate
House/ to Senate
House/ 2nd reading
House/ 3rd reading
House/ Rules to 3rd Reading Calendar
House/ passed 3rd reading
House/ to Senate
Senate/ concurs with House amendment
Senate/ placed on Concurrence Calendar
Senate/ received from House
Senate/ to House
LFA/ fiscal note publicly available for SB0170S04
LFA/ fiscal note publicly available for SB0170S04
LFA/ fiscal note sent to sponsor for SB0170S04
LFA/ fiscal note sent to sponsor for SB0170S04
House Comm - Amendment Recommendation
House Comm - Favorable Recommendation
House Comm - Substitute Recommendation
House/ comm rpt/ substituted/ amended
House/ return to Rules due to fiscal impact
LFA/ bill assigned to staff for fiscal analysis for SB0170S04
LFA/ bill sent to agencies for fiscal input for SB0170S04
House/ to standing committee
House/ 1st reading (Introduced)
House/ received from Senate
Senate/ passed 3rd reading
Senate/ to House
Senate/ uncircled
LFA/ fiscal note publicly available for SB0170S03
LFA/ fiscal note sent to sponsor for SB0170S03
LFA/ bill assigned to staff for fiscal analysis for SB0170S03
LFA/ bill sent to agencies for fiscal input for SB0170S03
Senate/ 3rd reading
Senate/ circled
Senate/ circled
Senate/ substituted
Senate/ uncircled
Senate/ passed 2nd reading
Senate/ substituted
Senate/ uncircled
LFA/ fiscal note publicly available for SB0170S02
LFA/ fiscal note sent to sponsor for SB0170S02
LFA/ bill assigned to staff for fiscal analysis for SB0170S02
LFA/ bill sent to agencies for fiscal input for SB0170S02
Senate/ 2nd reading
Senate/ circled
LFA/ fiscal note publicly available for SB0170S01
LFA/ fiscal note sent to sponsor for SB0170S01
LFA/ bill assigned to staff for fiscal analysis for SB0170S01
LFA/ bill sent to agencies for fiscal input for SB0170S01
Senate/ committee report favorable
Senate/ placed on 2nd Reading Calendar
Senate Comm - Favorable Recommendation
LFA/ fiscal note publicly available for SB0170
Senate/ received fiscal note from Fiscal Analyst
Senate/ to standing committee
LFA/ fiscal note sent to sponsor for SB0170
Senate/ 1st reading (Introduced)
Bill Numbered but not Distributed
LFA/ bill assigned to staff for fiscal analysis for SB0170
LFA/ bill sent to agencies for fiscal input for SB0170
Numbered Bill Publicly Distributed
Senate/ received bill from Legislative Research
This bill addresses vitamin K for newborn infants.
3 26B-4-327 26B-4-327 0 Vitamin K Amendments 2026 GENERAL SESSION STATE OF UTAH Chief Sponsor: Jen Plumb House Sponsor: Raymond P. Ward LONG TITLE General Description: This bill addresses vitamin K for newborn infants. Highlighted Provisions: This bill: requires a health care provider to educate a parent regarding the administration of vitamin K to a newborn infant; provides a process for a parent to decline administration of vitamin K; and defines terms. Money Appropriated in this Bill: None Other Special Clauses: None Utah Code Sections Affected: ENACTS: 26B-4-327 , Utah Code Annotated 1953 Be it enacted by the Legislature of the state of Utah: Section 1. Section 26B-4-327 is enacted to read: 26B-4-327 . Vitamin K newborn administration. (1) As used in this section "health care provider" means the same as that term is defined in Section 78B-3-403 . (2) A health care provider that provides care to a mother during the birth of a child shall provide a full and clear explanation of the risks and benefits of vitamin K administration and the risks of possible adverse health outcomes for a newborn that does not receive vitamin K. (3) A parent may decline to consent to the administration of vitamin K. Section 2. Effective Date. This bill takes effect on May 6, 2026 . 3-11-26 3:01 PM